| 1/12/2026 | BK | Market Commentary: Grant Thornton wraps upsized incremental; Hillenbrand, Belron, Astoria and more set talk
|
| 1/12/2026 | CLHY | Market Commentary: Grant Thornton wraps upsized incremental; Hillenbrand, Belron, Astoria and more set talk
|
| 7/8/2025 | HY | New Issue: Amynta prices $350 million eight-year notes at par to yield 7˝%
|
| 7/8/2025 | BKDDHY | Moody's rates Amynta notes Caa2
|
| 7/7/2025 | BKDDHY | S&P assigns Amynta notes CCC+
|
| 7/7/2025 | HY | Amynta to sell $350 million eight-year notes on Tuesday; initial talk high-7% area
|
| 12/5/2024 | BK | Market Commentary: Hexion, Calpine, Bright Horizons, Starwood, Waystar, Travel + Leisure and more break
|
| 12/2/2024 | BK | Market Commentary: Dechra updated; Culligan, Vistra, BrightSpring, CQP, Innio, Starwood and many more set talk
|
| 6/5/2024 | BK | Moody’s cuts Amynta loan ratings
|
| 6/4/2024 | CLHY | Market Commentary: Ecovyst breaks, Acrisure, Novaria, CQP revised; Harbor, PCI, Amynta, Medline accelerated
|
| 2/14/2023 | BK | Amynta finalizes $1.04 billion term loan B at 97 OID, adds CSA
|
| 2/7/2023 | CLHY | Market Commentary: Inspire Brands, American Airlines accelerate deadlines; Asurion, Amynta disclose talk
|
| 2/7/2023 | BK | Amynta launches $1.04 billion term loan B at SOFR plus 500 bps
|
| 2/6/2023 | BK | S&P assigns B- to Amynta loans
|
| 2/6/2023 | BK | Amynta readies launch of $1.04 billion term loan B for Tuesday
|
| 11/17/2022 | BK | Moody’s gives B2 to Amynta loan
|
| 11/17/2022 | BK | S&P rates Amynta add-on B-
|
| 2/20/2019 | BK | Moody's: Amynta unchanged on loan add-on
|
| 10/15/2018 | BK | Moody’s affirms Amynta
|
